#United States #New York #APAO #ReachRx #Oncology PA

APAO and ReachRx Announce a New Partnership to Enhance Resources for Oncology PAs

In a game-changing initiative, the Association of PAs in Oncology (APAO) has teamed up with ReachRx, a leader in AI-driven clinical knowledge access, to significantly improve the education and resource availability for oncology Physician Assistants (PAs). This collaboration, announced on January 13, 2025, aims to bolster the support structure available to oncology PAs, crucial players in the healthcare system.

What the Partnership Entails

As part of this partnership, ReachRx will offer all APAO members premium access to its cutting-edge clinical platform. This innovative platform provides oncology PAs with on-the-spot access to trusted information tailored specifically to their needs, helping them make better-informed clinical decisions swiftly. In addition to this, APAO’s extensive library of oncology resources—which includes educational materials, webinars, and clinical insights—will be seamlessly integrated into the ReachRx platform. This combination of resources will create a holistic experience for users seeking critical oncology information.

Tiffany Marie Statler, DMSc, PA-C, who serves as the President of APAO, expressed enthusiasm about this collaboration, stating, "We’re proud to partner with ReachRx to bring our members an invaluable tool that enhances their ability to find precise, up-to-date oncology information at the point of care." This sentiment reflects the partnership’s potential to uplift the standard of care delivered by oncology PAs.

A Shared Commitment to Education and Clinical Tools

Both organizations are deeply committed to improving access to essential educational tools and clinical information. ReachRx has developed its platform in consultation with healthcare professionals, ensuring it directly addresses the needs of its users. The goal is to make access to pivotal data as efficient as possible, allowing oncology PAs to devote their energies to providing exceptional patient care rather than spending excessive time on information retrieval.

Jeff DeVico, Co-founder and CEO of ReachRx, highlighted the importance of oncology PAs, saying, "Oncology PAs play a critical role in the care team, bridging gaps and overseeing a patient’s care journey from diagnosis through treatment and beyond." This highlights their crucial involvement in managing patient care and the need for accessible, reliable information.

Launch Details and Future Offering

This partnership is officially launching on January 13, 2025. As a perk of their membership, APAO members will gain complimentary premium access to ReachRx. Moreover, additional partnership features—including integrated educational resources and analytics tools—will be rolled out shortly after the launch. This ongoing development promises to keep oncology PAs informed of the latest medical advancements while they assist patients in navigating their treatment journeys.

For APAO members eager to access these new resources, further information and guidance will be available via the APAO website or by directly contacting the organization.

About ReachRx

ReachRx specializes in providing healthcare professionals with instant access to comprehensive information on drugs, disease states, and treatment options. Its AI-powered clinical search engine allows providers to quickly find actionable insights that enhance diagnostic and treatment decisions, aligning with the overarching aim of elevating patient outcomes. Learn more about ReachRx at their website.